Express Scripts set a precedent for new, high-priced drugs in the US when the pharmacy benefit manager (PBM) negotiated a deal with AbbVie that gives the pharma company's recently approved four-pill regimen Viekira Pak exclusive reimbursement for patients with genotype 1 hepatitis C.
Unless genotype 1 patients fail or can't tolerate Viekira, the agreement excludes coverage for other new hepatitis C virus (HCV)...






![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
